Benchmark Research Honored With Industry Accolades

Benchmark research recognized at the annual conferences of the Association of Clinical Research Professionals and the World Vaccine Congress

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Austin, Texas (PRWEB) April 26, 2013

Benchmark Research is honored to be recognized by two industry leading professional organizations, the Association of Clinical Research Professionals (ACRP) and the World Vaccine Congress (WVC), at their annual conferences last week.

ACRP awarded the 2013 Outstanding Leadership in Clinical Research Award for Leadership as a CRC to Benchmark’s Ann Rutledge, MA, CCRC, during their annual Global Conference & Exhibition in Orlando, Fla. on April 14. The award recognizes individuals who have made exceptional leadership/practice contributions that have furthered the vision and mission of ACRP.

Based at Benchmark’s Austin clinical research site, Ann is both Manager of Quality Control and a Senior Clinical Research Coordinator. She is recognized for her extensive experience developing and implementing site processes and standard operating procedures, as well as for creating and presenting training internally and for ACRP. “Being acknowledged for a focus on continuous quality improvement is very rewarding,” said Ann, who has more than 16 years of experience in clinical research and 26 years in the medical field. A Certified CRC since 2002, Ann was the founding chapter chair for the ACRP Central Texas Chapter.

The WVC recognized Benchmark’s Fort Worth site, part of VaxNet/Vax Consortium, as “Highly Recommended” and runner-up in the Best Clinical Site & Trial Network category at the Sixth Annual Vaccine Industry Excellence (ViE) Awards presented on April 17 in Washington, D.C. The only awards ceremony dedicated to the vaccine industry, the ViE Awards honor individuals, organizations and initiatives which have made significant contributions over the past 12 months.

Last year Benchmark’s Austin site took home the 2012 ViE award in the Best Clinical Trial Site category, while VaxNet was Highly Recommended and runner-up for the then-separate Best Site Network category. “We are honored to be recognized again for our commitment to excellence in vaccine research,” said Mark Lacy, founder and CEO of Benchmark Research. “Both the ACRP award to Ann and the ViE awards to our sites underscore the priority Benchmark places on raising the standard in clinical research.”


Contact

  • Andrew Kimball
    Benchmark Research
    469-854-0294
    Email